American Shared Hospital Services

The company maintains a capital structure characterized by zero long-term debt but significant short-term obligations of $16.8 million, resulting in a debt-to-equity ratio of 0.72. Liquidity is constrained, with a current ratio of 0.77 indicating that current liabilities exceed current assets, and net cash is negative after accounting for total debt. The firm holds $4.97 million in cash and equivalents against $16.84 million in short-term debt, creating a reliance on operating cash flow of $2.15 million to service obligations.

Profitability remains negative, with a net income loss of $612,000 and an operating income loss of $924,000 for the period, yielding a return on equity of -6.6% and a return on assets of -2.84%. The company generates a gross profit of $1.29 million on revenue of $7.08 million, but operating expenses exceed this margin, leading to negative earnings per share of $0.23. Valuation metrics reflect this distress, with a price-to-book ratio of 0.36 and a negative EV/EBITDA of -5.87.

Revenue concentration is not explicitly detailed by segment in the available data, but the company has expanded its direct patient service business model in the United States through acquisitions such as the RI Companies. The business model focuses on cancer treatment product offerings and direct patient services, diversifying its healthcare footprint.

Growth trajectory is difficult to assess from the single-period snapshot, but analyst estimates project mean revenue of $29.95 million, significantly higher than the last actual revenue of $28.08 million, suggesting expected expansion. However, the current quarterly revenue of $7.08 million represents a fraction of the annualized estimate, indicating potential seasonality or recent operational scaling.

Risk factors are elevated, with high liquidity risk and medium dilution risk flagged in the assessment. The company has disclosed going-concern or substantial-doubt language in its filings, citing the inability to repay the $22 million credit agreement with Fifth Third Bank if maturity is not extended. Events of Default have been discussed, and the company reassessed its ability to continue as a going concern.

Recent events include an 8-K filing with high severity material items, indicating significant corporate developments or disclosures. Analyst price targets remain at $4.00, implying a substantial upside from the current market price of $1.365, though this may reflect speculative recovery expectations rather than current fundamentals.

American Shared Hospital Services (AMS) has undergone a significant revision in its analytical profile, driven by a substantial downward adjustment in its estimated market share. The company’s calculated market share percentage dropped from approximately 3.40e-06 to 2.79e-08, representing a decline of 99.18%. This sharp contraction in the market share metric is the most material change recorded in the recent data update, signaling a major shift in how the company’s competitive position is quantified within the current analytical framework. This adjustment was part of a broader revision to the AI analysis narrative, business summary, and key takeaways, all sourced from the "ha_light_thesis" update. The narrative and conclusion fields were revised with low similarity scores of 0.072, indicating a near-complete overhaul of the descriptive text. Additionally, the key takeaways section saw a net neutral change in volume but a complete refresh in content, with seven new takeaways added and seven removed, reflecting a fundamental re-evaluation of the company's strategic outlook. Despite these significant internal data revisions, the summary of material changes notes that there was "no material change vs prior analysis" when excluding schema-expansion fields. This suggests that while the specific metrics and narrative descriptions have been updated, the core structural assessment of the company may remain consistent with previous evaluations, or that the changes are primarily methodological rather than indicative of new external events. The COMPANY_360 data for American Shared Hospital Services currently shows zero counts for officers, analysts, index memberships, and top holders. This lack of populated data points in the core profile fields limits the ability to contextualize the market share revision against broader market sentiment or ownership structures. Consequently, the significance of the market share drop remains isolated to the analytical model's output, without corroborating signals from analyst coverage or institutional holding changes in the available facts.

Analysts project 175.9% upside to a $4.00 target price, significantly above the current $1.45 market price.

Revenue grew at a 15.3% CAGR from FY2023 to FY2025, indicating consistent top-line expansion over the period.

Net income surged 240.8% year-over-year in the latest period, demonstrating significant profitability improvement momentum.

Debt-to-equity ratio of 0.72 is below the cohort median of 0.49, suggesting relatively conservative leverage compared to peers.

Operating margin of -12.78% places the company in the bottom quartile of the Integrated Oil & Gas cohort.

High liquidity risk is flagged, compounded by a current ratio of only 0.76, indicating potential short-term solvency issues.

Return on equity of -6.6% ranks in the bottom quartile, signaling poor capital efficiency relative to 185 cohort peers.

Net debt to EBITDA stands at 6.51, indicating high leverage and limited ability to service debt from operating earnings.

Revenue $7.1M; Operating income -$924.0k.

• ▍Revenue $7.1M
• ▍Operating income -$924.0k
• ▍Net margin -8.6%

Revenue $20.4M; Operating income -$2.2M.

• ▍Revenue $20.4M
• ▍Operating income -$2.2M
• ▍Net margin -4.5%

Revenue $13.2M; Operating income -$1.8M.

• ▍Revenue $13.2M
• ▍Operating income -$1.8M
• ▍Net margin -6.9%

Revenue $28.1M; Operating income -$3.6M.

• ▍Revenue $28.1M
• ▍Operating income -$3.6M
• ▍Net margin -5.5%

Revenue $28.3M; Operating income -$2.8M.

• ▍Revenue $28.3M
• ▍Operating income -$2.8M
• ▍Net margin 7.7%

Revenue $28.3M; Operating income -$2.8M.

• ▍Revenue $28.3M
• ▍Operating income -$2.8M
• ▍Net margin 7.7%

Revenue $21.3M; Operating income $270.0k.

• ▍Revenue $21.3M
• ▍Operating income $270.0k
• ▍Net margin 2.9%

Revenue $21.3M; Operating income $270.0k.

• ▍Revenue $21.3M
• ▍Operating income $270.0k
• ▍Net margin 2.9%